BridgeMD
New treatment option for Immunosenescence
Official title Interferon Reference for Older People - REFIPA Study
ClinicalTrials.gov ID: NCT07239830
What this study is testing
- What it's testing
- The diagnosis of respiratory viral infections is mainly based on PCR tests targeting the DNA or RNA of suspected viruses, including SARS-CoV-2, RSV and influenza viruses. However, this method is limited because it only tests for a small number of viruses, while many other pathogens can cause similar symptoms.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 80 and older. Healthy volunteers may be eligible.
You may be able to join if
- Subject aged 80 or over
- Patient admitted to the Charpennes hospital day unit or outpatient clinic for follow-up OR accompanying patient who receive care at the Charpennes...
- Weight greater than or equal to 45 kg
- Subject living in the Lyon metropolitan area
You likely can't join if
- people with symptoms of active infection (symptom questionnaire or temperature \> 37.5°C).
- people with an autoimmune disease linked to a dysregulated interferon response.
- people participating in another treatment study involving an exclusion period that is still ongoing or that may interfere with the present protocol.
- people deprived of their liberty by judicial or administrative decision
- people receiving psychiatric care
- Adults subject to legal protection measures (guardianship, curatorship)
See the full eligibility criteria
- Subject aged 80 or over
- Patient admitted to the Charpennes hospital day unit or outpatient clinic for follow-up OR accompanying patient who receive care at the Charpennes geriatric hospital OR subject recruited through the local press
- Weight greater than or equal to 45 kg
- Subject living in the Lyon metropolitan area
- people with symptoms of active infection (symptom questionnaire or temperature \> 37.5°C).
- people with an autoimmune disease linked to a dysregulated interferon response.
- people participating in another treatment study involving an exclusion period that is still ongoing or that may interfere with the present protocol.
- people deprived of their liberty by judicial or administrative decision
- people receiving psychiatric care
- Adults subject to legal protection measures (guardianship, curatorship)
- people not affiliated with a social security scheme or beneficiaries of a similar scheme
The study team makes the final eligibility decision.
Where it's taking place
- Villeurbanne, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 80 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Villeurbanne, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.